Particulate matter disrupts human lung endothelial cell barrier integrity via Rho-dependent pathways.

Abstract:

:Increased exposure to ambient particulate matter (PM) is associated with elevated morbidity and mortality in patients with cardiopulmonary diseases and cancer. We and others have shown that PM induces lung microvascular barrier dysfunction which potentially enhances the systemic toxicity of PM. However, the mechanisms by which PM disrupts vascular endothelial integrity remain incompletely explored. We hypothesize that PM induces endothelial cell (EC) cytoskeleton rearrangement via Rho GTPase-dependent pathways to facilitate vascular hyperpermeability. Fine PM induced time-dependent activation of cytoskeletal machinery with increases in myosin light chain (MLC) phosphorylation and EC barrier disruption measured by transendothelial electrical resistance (TER), events attenuated by the Rho-dependent kinase (ROCK) inhibitor Y-27632 or the reactive oxygen species (ROS) scavenger, N-acetylcysteine (NAC). Both Y-27632 and NAC prevented PM-induced stress fiber formation and phospho-MLC accumulation in human lung ECs. PM promotes rapid accumulation of Rho-GTP. This event is attenuated by NAC or knockdown of RhoA (siRNA). Consistent with ROCK activation, PM induced phosphorylation of myosin light chain phosphatase (MYPT) at Thr850, a post-translational modification known to inhibit phosphatase activity. Furthermore, PM activates the guanine nucleotide exchange factor (GEF) for Rho, p115, with p115 translocation to the cell periphery, in a ROS-dependent manner. Together these results demonstrate that fine PM induces EC cytoskeleton rearrangement via Rho-dependent pathways that are dependent upon the generation of oxidative stress. As the disruption of vascular integrity further contributes to cardiopulmonary physiologic derangements, these findings provide pharmacologic targets for prevention of PM-induced cardiopulmonary toxicity.

journal_name

Pulm Circ

journal_title

Pulmonary circulation

authors

Wang T,Shimizu Y,Wu X,Kelly GT,Xu X,Wang L,Qian Z,Chen Y,Garcia JGN

doi

10.1086/689906

subject

Has Abstract

pub_date

2017-07-01 00:00:00

pages

617-623

issue

3

eissn

2045-8932

issn

2045-8940

journal_volume

7

pub_type

杂志文章
  • Addition of a bilateral access form of peripheral extracorporeal membrane oxygenation rescued a patient with idiopathic pulmonary arterial hypertension who developed circulatory collapse immediately after childbirth.

    abstract::Pregnancy is not advised for patients with Pulmonary hypertension (PH) because of high risk of PH crisis. However, some patients have undiagnosed idiopathic pulmonary arterial hypertension (IPAH) before pregnancy. Upfront combination therapy has high efficacy for patients with IPAH. However, some patients are unable t...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045894020910140

    authors: Adachi S,Shimokata S,Yoshida M,Imai R,Nakano Y,Okumura N,Suzuki S,Murohara T,Kondo T

    更新日期:2020-02-28 00:00:00

  • Reactive oxygen species scavengers improve voltage-gated K(+) channel function in pulmonary arteries of newborn pigs with progressive hypoxia-induced pulmonary hypertension.

    abstract::Abstract Changes in voltage-gated K(+) (Kv) channel function contribute to the pathogenesis of pulmonary hypertension. Yet the mechanisms underlying Kv channel impairments in the pulmonary circulation remain unclear. We tested the hypothesis that reactive oxygen species (ROSs) contribute to the Kv channel dysfunction ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/674307

    authors: Fike CD,Aschner JL,Kaplowitz MR,Zhang Y,Madden JA

    更新日期:2013-09-01 00:00:00

  • Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing.

    abstract::Pulmonary capillary hemangiomatosis (PCH) is a rare form of pulmonary arterial hypertension (PAH) characterized by pulmonary capillary proliferation and pseudoinvasion of collagenous septal structures. PCH is often accompanied by veno-occlusive changes and pulmonary hypertensive arterial remodeling. The clinical and p...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1086/682227

    authors: DuBrock HM,Kradin RL,Rodriguez-Lopez JM,Channick RN

    更新日期:2015-09-01 00:00:00

  • Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.

    abstract::There are few data on the epidemiology of pulmonary hypertension (PH)-related hospitalizations in children in the United States. Our aim was to determine hospital mortality, length of hospitalization, and hospital charges pertaining to PH-related hospitalizations and also the effects of codiagnoses and comorbidities. ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/681226

    authors: Frank DB,Crystal MA,Morales DL,Gerald K,Hanna BD,Mallory GB Jr,Rossano JW

    更新日期:2015-06-01 00:00:00

  • Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients.

    abstract::The biological mechanisms behind the development of pulmonary hypertension in the setting of left heart failure (HF-PH), including combined pre- and post-capillary pulmonary hypertension (Cpc-PH), remains unclear. This study aimed to use candidate polymorphisms in nitric oxide synthase (NOS) genes to explore the role ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018773049

    authors: Duarte JD,Kansal M,Desai AA,Riden K,Arwood MJ,Yacob AA,Stamos TD,Cavallari LH,Zamanian RT,Shah SJ,Machado RF

    更新日期:2018-04-01 00:00:00

  • A non-selective endothelin receptor antagonist bosentan modulates kinetics of bone marrow-derived cells in ameliorating pulmonary hypertension in mice.

    abstract::The aim of this study was to investigate whether a dual endothelin receptor antagonist bosentan modulates the kinetics of bone marrow-derived stem cells in inhibiting the development of pulmonary hypertension. Bone marrow chimeric mice, transplanted with enhanced green fluorescent protein (eGFP)-positive bone marrow m...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894020919355

    authors: Kato T,Mitani Y,Masuya M,Maruyama J,Sawada H,Ohashi H,Ikeyama Y,Otsuki S,Yodoya N,Shinohara T,Miyata E,Zhang E,Katayama N,Shimpo H,Maruyama K,Komada Y,Hirayama M

    更新日期:2020-05-14 00:00:00

  • Idiopathic hypereosinophilic syndrome with pulmonary hypertension.

    abstract::Hypereosinophilic syndrome is a myeloproliferative disorder characterized by persistent eosinophilia with involvement of multiple organs. The occurrence of severe pulmonary hypertension (PH) in the setting of hypereosinophilic syndrome is very uncommon. A 43-year-old man with documented idiopathic hypereosinophlic syn...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045894018793999

    authors: Zhang L,Peng X,Adhikari BK,Li B,Liu Q,Mikeladze J,Zhang W

    更新日期:2019-01-01 00:00:00

  • Effects of exercise rehabilitation training on patients with pulmonary hypertension.

    abstract::Pulmonary hypertension (PH) comprises a group of pathophysiological syndromes characterized by elevated pulmonary artery pressure and pulmonary vascular resistance, which lead to right ventricular overload, and even right heart failure. PH has a poor prognosis and severely leads to a decline in quality of life. Histor...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1177/2045894020937129

    authors: Zhang X,Xu D

    更新日期:2020-07-07 00:00:00

  • Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial.

    abstract::Inhaled iloprost is an effective therapy for patients with pulmonary arterial hypertension (PAH); however, some patients experience extended inhalation times when using the V10 formulation (10.0 µg/mL) to deliver a 5 -µg dose (at mouthpiece) and are at risk of incomplete inhalations and reduced inhalation frequency. V...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018798921

    authors: Richter MJ,Stollfuß B,Roitenberg A,Kleinjung F,Graeff V,Berghaus S,Müller C,Ghofrani HA

    更新日期:2018-10-01 00:00:00

  • Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysis.

    abstract::Pulmonary arterial hypertension (PAH) patients have distinct disease courses and responses to treatment, but current diagnostic and treatment schemes provide limited insight. We aimed to see if cluster analysis could distinguish clinical phenotypes in PAH. An unbiased cluster analysis was performed on 17 baseline clin...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217705891

    authors: Parikh KS,Rao Y,Ahmad T,Shen K,Felker GM,Rajagopal S

    更新日期:2017-04-01 00:00:00

  • Retinal vascular changes and right ventricular structure and function: the MESA-Right Ventricle and MESA-Eye studies.

    abstract::Retinal vessel diameters have been associated with left ventricular morphology and function but their relationship with the right ventricle (RV) has not been studied. We hypothesized that wider retinal venules and narrower retinal arterioles are associated with RV morphology and function. RV end-diastolic mass (RVEDM)...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018819781

    authors: Chyou AC,Klein BEK,Klein R,Barr RG,Cotch MF,Praestgaard A,Wong TY,Lima J,Bluemke DA,Kawut S

    更新日期:2018-12-03 00:00:00

  • Current organization of specialist pulmonary hypertension clinics: results of an international survey.

    abstract::Optimal pulmonary hypertension (PH) management relies on a timely, accurate diagnosis and follow-up in specialized clinics by multidisciplinary teams that have clearly defined responsibilities and protocols. Internationally agreed criteria for expert center staff are lacking, particularly with respect to nurses, who o...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019855611

    authors: Doyle-Cox C,Nicholson G,Stewart T,Gin-Sing W

    更新日期:2019-04-01 00:00:00

  • Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension.

    abstract::Atrial arrhythmias are common during episodes of acute respiratory failure in patients with chronic lung disease-associated pulmonary hypertension. Expert opinion suggests that management of atrial arrhythmias in patients with pulmonary hypertension should aim to restore sinus rhythm. This is clinically challenging in...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1177/2045894020910685

    authors: Vahdatpour CA,Luebbert JJ,Palevsky HI

    更新日期:2020-03-09 00:00:00

  • Pulmonary thromboembolism with computed tomography defined chronic thrombus is associated with higher mortality.

    abstract::With the advancement of computed tomography pulmonary angiography, differentiating between acute and chronic thrombus in pulmonary embolism has become more feasible. However, whether pulmonary embolism with chronic thrombus contributes to a higher mortality than pulmonary embolism with acute thrombus remains undetermi...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894020905510

    authors: Chang HY,Chang WT,Chen PW,Lin CC,Hsu CH

    更新日期:2020-05-01 00:00:00

  • Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy.

    abstract::Pulmonary arterial hypertension (PAH) is a progressive and debilitating condition. Despite promoting vasodilation, current drugs have a therapeutic window within which they are limited by systemic side effects. Nanomedicine uses nanoparticles to improve drug delivery and/or reduce side effects. We hypothesize that thi...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217710224

    authors: Mohamed NA,Davies RP,Lickiss PD,Ahmetaj-Shala B,Reed DM,Gashaw HH,Saleem H,Freeman GR,George PM,Wort SJ,Morales-Cano D,Barreira B,Tetley TD,Chester AH,Yacoub MH,Kirkby NS,Moreno L,Mitchell JA

    更新日期:2017-07-01 00:00:00

  • Dosing characteristics of oral treprostinil in real-world clinical practice.

    abstract::Pharmacokinetic studies with oral treprostinil demonstrate that three times daily (TID) dosing reduces peak-to-trough plasma trepostinil fluctuations compared with twice daily (BID) dosing. TID dosing may allow for faster titration, higher total daily doses, and potentially improve the tolerability of oral trepostinil...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018770654

    authors: Balasubramanian VP,Messick CR,Broderick M,Nelsen AC

    更新日期:2018-04-01 00:00:00

  • "Anagrelide-induced pulmonary arterial hypertension": a rare case of drug-induced pulmonary arterial hypertension.

    abstract::Pulmonary arterial hypertension can be associated with exposure to certain drugs or toxins. However, only a few cases of drug-induced pulmonary arterial hypertension have been previously reported. Anagrelide is an oral imidazoquinazoline agent that is prescribed for reducing elevated platelet counts in patients with m...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045894019896682

    authors: Sumimoto K,Taniguchi Y,Matsuoka Y,Onishi H,Emoto N,Hirata KI

    更新日期:2019-12-27 00:00:00

  • Mechanical forces stimulate endothelial microparticle generation via caspase-dependent apoptosis-independent mechanism.

    abstract::Microparticle release by vascular endothelium has been implicated in various cardiovascular pathologies. Ventilator-induced lung injury (VILI) is a life-threatening complication of mechanical ventilation at high tidal volumes associated with excessive mechanical stretch of pulmonary vascular endothelial cells. However...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.109921

    authors: Vion AC,Birukova AA,Boulanger CM,Birukov KG

    更新日期:2013-01-01 00:00:00

  • Compensated right ventricular function of the onset of pulmonary hypertension in a rat model depends on chamber remodeling and contractile augmentation.

    abstract::Right-ventricular function is a good indicator of pulmonary arterial hypertension (PAH) prognosis; however, how the right ventricle (RV) adapts to the pressure overload is not well understood. Here, we aimed at characterizing the time course of RV early remodeling and discriminate the contribution of ventricular geome...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018800439

    authors: Vélez-Rendón D,Zhang X,Gerringer J,Valdez-Jasso D

    更新日期:2018-10-01 00:00:00

  • Advancing clinical trial design in pulmonary hypertension.

    abstract::In pulmonary hypertension, as in many other diseases, there is a need for a smarter approach to evaluating new treatments. The traditional randomized controlled trial has served medical science well, but constrains the development of treatments for rare diseases. A workshop was established to consider alternative clin...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.109933

    authors: Grieve AP,Chow SC,Curram J,Dawe S,Harnisch LO,Henig NR,Hung HM,Ivy DD,Kawut SM,Rahbar MH,Xiao S,Wilkins MR

    更新日期:2013-01-01 00:00:00

  • Molecular and functional significance of Ca(2+)-activated Cl(-) channels in pulmonary arterial smooth muscle.

    abstract::Increased peripheral resistance of small distal pulmonary arteries is a hallmark signature of pulmonary hypertension (PH) and is believed to be the consequence of enhanced vasoconstriction to agonists, thickening of the arterial wall due to remodeling, and increased thrombosis. The elevation in arterial tone in PH is ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1086/680189

    authors: Leblanc N,Forrest AS,Ayon RJ,Wiwchar M,Angermann JE,Pritchard HA,Singer CA,Valencik ML,Britton F,Greenwood IA

    更新日期:2015-06-01 00:00:00

  • Racial differences in patients referred for right heart catheterization and risk of pulmonary hypertension.

    abstract::African Americans (AA) have a higher incidence of pulmonary hypertension (PH) risk factors. Few studies have examined the racial differences in the prevalence and etiology of PH and direct comparison of invasive hemodynamics between AAs and Caucasians has rarely been reported. In this study, we examined whether racial...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018764273

    authors: Yang BQ,Assad TR,O'Leary JM,Xu M,Halliday SJ,D'Amico RW,Farber-Eger EH,Wells QS,Hemnes AR,Brittain EL

    更新日期:2018-04-01 00:00:00

  • Pulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA.

    abstract::Pulmonary arterial hypertension (PAH) is characterized by obstruction of pre-capillary pulmonary arteries, which leads to sustained elevation of pulmonary arterial pressure. Identifying those at risk through early interventions, such as genetic testing, may mitigate disease course. Current practice guidelines recommen...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217700156

    authors: Jacher JE,Martin LJ,Chung WK,Loyd JE,Nichols WC

    更新日期:2017-04-01 00:00:00

  • Echocardiographic assessment of right ventricular function in experimental pulmonary hypertension.

    abstract::Echocardiography, a non-invasive and cost-effective method for monitoring cardiac function, is commonly used for evaluation and pre-clinical diagnostics of pulmonary hypertension (PH). Previous echocardiographic studies in experimental models of PH are fragmentary in terms of the evaluation of right ventricle (RV) fun...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019841987

    authors: Zhu Z,Godana D,Li A,Rodriguez B,Gu C,Tang H,Minshall RD,Huang W,Chen J

    更新日期:2019-04-01 00:00:00

  • Reducing rates of readmission and development of an outpatient management plan in pulmonary hypertension: lessons from congestive heart failure management.

    abstract::Pulmonary hypertension currently has minimal guidelines for outpatient disease management. Congestive heart failure studies, however, have shown effectiveness of disease management plans in reducing all-cause mortality and all-cause and congestive heart failure-related hospital readmissions. Heart failure exacerbation...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894020968471

    authors: Dolan J,Mandras S,Mehta JP,Navas V,Tarver J,Chakinala M,Rahaghi F

    更新日期:2020-12-07 00:00:00

  • Effects of oxygen therapy in a pediatric normoxemic patient with pulmonary arterial hypertension and congenital heart disease.

    abstract::To shed light on the efficacy of oxygen therapy in pulmonary arterial hypertension (PAH) when hypoxemia is not present, we report seven years of observational data for a female patient recorded between February 2012 and February 2019 when she was aged 7.8-14.8 years. The patient was born with an atrial septal defect (...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019845610

    authors: Green S,Stuart D

    更新日期:2019-04-01 00:00:00

  • Rescue balloon pulmonary angioplasty in a rapidly deteriorating chronic thromboembolic pulmonary hypertension patient with liver failure and refractory infection.

    abstract::Pulmonary endarterectomy (PEA) is the standard therapy for chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) is an alternative therapy for such patients. Here we report the case of a 60-year-old woman who presented with severe CTEPH resulting in low cardiac output and liver fai...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1086/675643

    authors: Tsuji A,Ogo T,Demachi J,Ono Y,Sanda Y,Morita Y,Fukuda T,Nakanishi N

    更新日期:2014-03-01 00:00:00

  • The unique heart sound signature of children with pulmonary artery hypertension.

    abstract::We hypothesized that vibrations created by the pulmonary circulation would create sound like the vocal cords during speech and that subjects with pulmonary artery hypertension (PAH) might have a unique sound signature. We recorded heart sounds at the cardiac apex and the second left intercostal space (2LICS), using a ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/683694

    authors: Elgendi M,Bobhate P,Jain S,Guo L,Kumar S,Rutledge J,Coe Y,Zemp R,Schuurmans D,Adatia I

    更新日期:2015-12-01 00:00:00

  • Change in R wave in lead V1 predicts survival of patients with pulmonary arterial hypertension.

    abstract::Clinical guidelines for pulmonary hypertension recommend evaluating treatment response through various methods; however, electrocardiography (ECG) is not included as one of the methods of choice. We aimed to identify ECG parameters that correlated with prognosis in patients with pulmonary arterial hypertension (PAH). ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018776496

    authors: Sato S,Ogawa A,Matsubara H

    更新日期:2018-04-01 00:00:00

  • Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food.

    abstract::Riociguat is approved for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Some patients have difficulty swallowing tablets; therefore, 2 randomized, nonblinded, crossover studies compared the relative bioavailability of riociguat oral suspensions and immediate-releas...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/685020

    authors: Saleh S,Frey R,Becker C,Unger S,Wensing G,Mück W

    更新日期:2016-03-01 00:00:00